Athira Pharma, Inc. (ATHA)
NASDAQ: ATHA · Real-Time Price · USD
0.2700
+0.0157 (6.17%)
At close: May 12, 2025, 4:00 PM
0.2565
-0.0135 (-5.00%)
After-hours: May 12, 2025, 5:49 PM EDT
Athira Pharma Market Cap
Athira Pharma has a market cap or net worth of $10.54 million as of May 12, 2025. Its market cap has decreased by -86.32% in one year.
Market Cap
10.54M
Enterprise Value
-25.01M
1-Year Change
-86.32%
Ranking
Category
Stock Price
$0.27
Market Cap Chart
Since the IPO on September 18, 2020, Athira Pharma's market cap has decreased from $489.85M to $10.54M, a decrease of -97.85%. That is a compound annual growth rate of -56.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 9.93M | -56.24% |
| Dec 31, 2024 | 22.69M | -75.47% |
| Dec 29, 2023 | 92.47M | -22.89% |
| Dec 30, 2022 | 119.92M | -75.36% |
| Dec 31, 2021 | 486.68M | -56.26% |
| Dec 31, 2020 | 1.11B | 127.14% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.30B |
| Johnson & Johnson | 370.87B |
| UnitedHealth Group | 343.58B |
| AbbVie | 335.74B |
| Novo Nordisk | 292.03B |
| Abbott Laboratories | 229.64B |
| Novartis AG | 213.30B |
| AstraZeneca | 210.42B |